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Abstract Leptin is an adipocyte-derived hormone
involved in a myriad of physiological process, including
the control of energy balance and several neuroendocrine
axes. Leptin-deficient mice and humans are obese, diabetic,
and display a series of neuroendocrine and autonomic
abnormalities. These individuals are infertile due to a lack
of appropriate pubertal development and inadequate syn-
thesis and secretion of gonadotropins and gonadal steroids.
Leptin receptors are expressed in many organs and tissues,
including those related to the control of reproductive
physiology (e.g., the hypothalamus, pituitary gland, and
gonads). In the last decade, it has become clear that leptin
receptors located in the brain are major players in most
leptin actions, including reproduction. Moreover, the recent
development of molecular techniques for brain mapping
and the use of genetically modified mouse models have
generated crucial new findings for understanding leptin
physiology and the metabolic influences on reproductive
health. In the present review, we will highlight the new
advances in the field, discuss the apparent contradictions,
and underline the relevance of this complex physiological
system to human health. We will focus our review on the
hypothalamic circuitry and potential signaling pathways
relevant to leptin’s effects in reproductive control, which
have been identified with the use of cutting-edge technol-
ogies of molecular mapping and conditional knockouts.
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Introduction
Leptin is a hormone primarily synthesized and secreted
by the white adipose tissue [362]. It is encoded by the
Lep/LEP gene (previously named ob gene, for obese) and
circulates in the plasma in free and bound forms. Leptin
receptors, encoded by Lepr/LEPR gene are found in six
isoforms expressed in a variety of organs and cell types
[4, 75, 124, 238, 243, 318, 361]. In the last 15 years or so,
leptin’s crucial role in multiple endocrine, metabolic and
autonomic functions has been unraveled. In the present
review, we will highlight the role of leptin in the control of
the reproductive neuroendocrine axis. Innumerous studies
have described a critical role for leptin in gonadal function,
uterine physiology, pregnancy, and implantation, which
will not be explored in this review. For discussions on these
issues, we recommend consulting the following articles
[40, 51, 130, 150, 166, 207, 271, 321]. Herein, we will give
special attention to recent advances in the identification of
key hypothalamic sites and signaling pathways relevant for
leptin’s action in reproductive control.
Leptin action as a signal of energy sufficiency
Under physiologic conditions, circulating levels of leptin
are highly correlated with stored adipocyte mass [83, 215,
362]. Leptin levels fall quickly during starvation, in
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parallel with the stereotypical response of various neuro-
endocrine systems and, therefore, fluctuations in the levels
of leptin are viewed as a key metabolic cue for the neu-
roendocrine adaptations that occur during negative energy
balance [6, 61, 68, 124]. Falling leptin levels signal energy
insufficiency, inducing counter-regulatory responses to
preserve or accumulate energy. Increases in appetite and
motivation for food search, decreases in thermogenesis and
locomotor activity, inhibition of the thyroid axis and acti-
vation of the hypothalamic–pituitary–adrenal axis are
examples of critical adaptive responses [2]. Additionally,
likely due to the high energetic costs of reproductive pro-
cesses such as pregnancy and lactation, states of negative
energy balance rapidly inhibit the reproductive function.
Fasting rodents and primates exhibit decreases in sex ste-
roids, pulsatile luteinizing hormone (LH) secretion and
fertility [52–54, 215, 221, 258, 339]. Studies from several
laboratories, using different species and paradigms, have
demonstrated that leptin administration blunts the fasting-
induced suppression of LH secretion, restores female
cyclicity and improves fertility [5, 140]. In mice, 48 h of
food deprivation led to decreased LH levels and longer
estrous cycles. Chronic leptin administration sustained
elevated LH secretion and precluded estrus delay [5].
Likewise, chronic administration of leptin prevented the
reduction of LH pulse frequency in fasted female rats, and
maintenance of steady physiologic levels of leptin allowed
a preovulatory LH surge in fasted rats [245, 337] (but see
also [324]). Acute leptin administration to food-deprived
male or female rats induced a rapid increase in LH pulse
frequency and amplitude [98, 140], and intracerebroven-
tricular administration of leptin antiserum disrupted
cyclicity and LH secretion in fed rats [60].
Similar effects of leptin are less clear in non-human
primates as only very high doses of leptin can sustain LH
levels in fasted monkeys [122, 191, 192, 220]. Moreover,
seasonal breeders (e.g., sheep and hamsters) appear to have
evolved divergent strategies to assure reproductive success,
favoring photoperiodic cues over metabolic signals. For
discussion of species differences and contradictions please
see [262, 288]. However, as a valuable proof-of-principle,
leptin treatment increased pulse frequency and mean levels
of LH, estradiol, ovarian volume and number of dominant
follicles in women with hypothalamic amenorrhea result-
ing from extreme exercise and weight loss [68, 206, 234,
335, 341]. Therefore, despite species differences and con-
troversies in the field, it is now well-accepted that leptin is
a key metabolic cue that signals energy sufficiency to
control adequacy and timing of reproductive function.
Recently, a series of compounds with the ability of
blocking leptin action were produced, including leptin
antagonists and antibodies against the leptin binding
domain of LepR [120, 254, 303]. With these tools,
temporary/reversible blockade of leptin action became
feasible and, therefore, the use of these compounds is
expected to contribute to our understanding of leptin
physiology. For example, treatment of rats with leptin
antagonist during early postnatal life impaired the appro-
priate development of several organs, including ovaries
with marked decrease of primordial follicles [12]. This
study highlights a previously unrecognized role of leptin in
postnatal maturation of reproductive organs.
Effects of leptin deficiency in the reproductive
neuroendocrine axis
The genetic mutation causing leptin deficiency was first
identified in C57BL/6 mice (named ob/ob, for obese) at
Jackson Laboratories [165]. The mutation was later defined
as autosomal recessive, and homozygotes are morbidly
obese due to hyperphagia and decreased energy expendi-
ture and display multiple neuroendocrine abnormalities
[79, 362]. Leptin-deficient mice of both sexes are infertile,
but some degree of reproductive capability has been
described in young ob/ob males [194]. At prepubertal
stages, the reproductive organs of ob/ob mice are indis-
tinguishable from wild-type, but neither males nor females
attain sexual maturation. Proper sexual development and
fertility is only achieved if leptin is provided [21, 70, 239].
The infertility phenotype observed in leptin-deficient mice
is dependent on genetic background, as obese ob/ob mice
crossed onto a BALB/cJ strain have improved fertility. The
effect of the so called, but yet unidentified, genetic modi-
fiers appears to be sexually dimorphic. Males from the F2
generation are partially fertile, whereas females only show
improved fertility after ten generations of backcrossing of
the ob mutation onto the BALB/cJ genetic background
[266].
The reproductive organs of leptin-deficient male and
female mice (in C57BL/6 background) display a series of
morphological and biochemical abnormalities. The weights
of ventral prostate and testes are decreased while the
reported weights of the seminal vesicles are variable [239,
317]. The seminiferous tubules contain fewer sperm and
the Leydig cells are reduced in size [239]. The uterus is
immature and ovaries have a comparable number of folli-
cles to wild-type mice at initial stages, but no mature
follicles or corpora lutea were detected [21]. The uterus
and ovaries respond adequately to exogenous estradiol and
gonadotropins [103, 193]. When transplanted to wild-type
females, ovaries of ob/ob mice produce sex steroids and
viable oocytes, and gametogenesis may be restored by
exogenous administration of gonadotropins [24, 161].
Leptin-deficient male and female mice show reduced
pituitary content of luteinizing hormone (LH) and
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increased pituitary content of follicle stimulating hormone
(FSH) [24, 317]. However, circulating levels of LH and
FSH are decreased in both male and female ob/ob mice.
Increased gonadotropin secretion can be induced by cas-
tration, although at a lower magnitude compared to the
wild-type [193, 317]. Notably, ob/ob mice are highly sen-
sitive to the suppressive effects of sex steroids on
gonadotropin secretion, consistent with a prepubertal con-
dition of high negative feedback restraint [317].
Gonadotropes of ob/ob mice respond adequately to gona-
dotropin releasing hormone (GnRH) challenges, and ob/ob
female mice can ovulate and become fertile if levels of
gonadotropins and sex steroids are maintained at physio-
logical ranges [161]. Interestingly, compared to the wild-
type, higher GnRH content is observed in the hypothala-
mus of adult ob/ob mice [24]. These findings indicate that
leptin-deficient mice have adequate development and
functioning of gonadotropes and gonads but deficient
GnRH secretion at the expected time of puberty onset.
Consistent with this concept, in vitro and in vivo studies
have determined that leptin acts primarily in the brain by
stimulating GnRH secretion [198, 199, 257, 347, 358].
Leptin signaling deficiency in humans
In humans, leptin signaling deficiency caused by genetic
mutations is a rare condition. In general, two forms of
congenital leptin signaling deficiency have been identified:
mutation in leptin (LEP) gene and mutation in leptin
receptor (LEPR) gene. Both comprise rare causes of
monogenic obesity and infertility. Individual heterozygotes
for LEP or LEPR genes mutation undergo puberty and
show apparently normal reproductive life. Therefore, only
one functional copy of LEP or LEPR genes is required for
the normal progression of sexual maturation and fertility.
Twenty-nine cases of loss-of-function of LEP gene and 20
cases of mutation impairing LEPR signaling have been
reported in the literature [77, 118, 119, 123, 129, 205, 227,
228, 259]. Affected individuals are usually born with
normal birth weights but rapidly gain weight in their first
few months of life. They exhibit hyperphagia with
aggressive behavior if food is denied, and become mor-
bidly obese. Failure of pubertal growth spurt and lack of
secondary sexual characteristics is usually observed [117].
However, one affected Turkish female with LEP gene
mutation began to have menses after a delay of 20 years. In
addition, three women with LEPR mutations had irregular
menses starting in their third to fourth decade of life, and
sex hormones were consistent with their age [255].
Recombinant leptin therapy to leptin-deficient subjects has
restored the gonatropic axis, induce puberty, correct men-
strual irregularities, increase height and reduce relative fat
mass [116]. No therapy has been described for subjects
with LEPR mutation.
The role of leptin deficiency in constitutional delay in
growth and puberty (CDGP) has also been investigated.
Subjects with CDGP have lower leptin levels compared to
normal controls [31, 137]. They are usually underweight
for their height exhibiting decreased adipose tissue mass
and low circulating levels of leptin and, therefore, the
delayed puberty onset has been interpreted as a conse-
quence of low leptin production [107]. A missense variant
in LEP gene was identified in one individual with CDGP
[241]. The sequence variant was also detected in his
mother that exhibited similar features of decreased fat mass
and delayed sexual maturation. Interestingly, this sequence
variant was associated with delayed puberty in the context
of decreased body mass index (BMI) rather than obesity.
Because of this unexpected outcome, further investigation
is necessary to determine if pubertal delay is directly
associated with deficient leptin signaling.
Leptin as a permissive factor for the onset of puberty
Many aspects of the reproductive physiology are energet-
ically demanding (e.g., territoriality for males or pregnancy
and lactation for females) and, therefore, the individual
nutritional condition is a key factor in the onset of puberty
[91, 108, 272, 322]. Seminal studies by Kennedy and Mitra
[182] showed that the time of puberty initiation in rats is
correlated with body size, not chronological age. Subse-
quently, a series of epidemiological studies in humans
proposed that a critical amount of body fat is required for
proper sexual maturation [126, 127]. Following its dis-
covery as an adipocyte-derived hormone in 1994, leptin
was readily recognized as the potential link between energy
stores (adiposity) and the progression of puberty.
Due to the infertility of the ob/ob mice and the complete
rescue of fertility following leptin administration, leptin
was initially hypothesized to be the key signal for the onset
of puberty. However, it soon became clear that leptin is
rather a permissive factor that is required, but not suffi-
cient, for normal sexual maturation. In this respect, a
critical evaluation of some apparent controversies is nec-
essary. Different laboratories have reported dissimilar
results on the ability of exogenous leptin to advance the
onset of puberty in rodents [3, 9, 72]. Leptin administration
at low concentrations, which are insufficient to alter
metabolism, in female mice induced an advance in the
onset of puberty [3]. In prepubertal female rats, leptin
increased the secretion of gonadotropin and the expression
of ovarian steroidogenesis enzymes and advanced puberty
[9]. In another study, leptin administration was linked to
decreased food consumption and did not advance the age at
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puberty onset. However, pair-fed mice used as controls in
this paradigm showed delayed puberty onset, suggesting
that leptin administration prevented the delayed pubertal
development caused by the negative energy balance [72,
73]. This finding is in agreement with studies showing that
maintenance of adequate leptin levels prevents pubertal
delay in conditions of negative energy balance [143]. In
this context, leptin also functions as a metabolic signal of
energy sufficiency, as previously discussed. Low leptin
levels induced by a negative energy balance halt sexual
maturation, which can be restored by leptin administration.
An additional argument in favor of a role for leptin in
puberty initiation would be the occurrence of changes in
leptin levels or signaling during the pubertal transition.
While still controversial, nocturnal increases in leptin
secretion before puberty have been observed in both rats and
primates [244, 314]. Moreover, mice overexpressing leptin
(transgenic skinny mice) showed early appearance of vaginal
opening followed by uterine and ovarian maturation, sug-
gestive of accelerated activity of the hypothalamus–
pituitary–gonads (HPG) axis [360]. The skinny female mice
also showed an advance in reproductive senescence, indi-
cating that in addition to the advance in the onset of puberty,
hyperleptinemia may promote reproductive failure at early
ages. Whether this represents a physiological correlation to
the dysfunctional activity of the HPG axis observed in obese
patients still needs to be demonstrated. Along the same lines,
recent studies have suggested that the hyperleptinemia
observed in young obesity or overnutrition may be the cause
of reported advances in the age of puberty onset [33, 62, 108,
322]. For more details and discussion, we recommend con-
sulting recently published articles focused on this specific
issue [7, 34, 49, 104, 108, 171].
Leptin signaling and the reproductive function
The LepR is a member of the class 1 cytokine receptor
family and is found in six isoforms, all derived from splice
variants of the LEPR/Lepr gene [75, 200, 318]. Of the six
isoforms, only the LepR long form (302 amino acids
intracellular domain) contains a Box 3 motif, which
enables the activation of the Janus kinase/signal transducer
and activator of transcription (JAK/STAT) signaling
pathway [36, 243, 354]. Binding of JAK2 to STAT3 leads
to its phosphorylation at Tyr1138 and translocation to the
nucleus where it functions as a transcription factor [19,
240]. Thus, the long-form of leptin receptor (a.k.a. LepRb)
is recognized as the physiologically relevant signaling
isoform. Consistent with this concept, loss-of-function
mutations of LEPR/Lepr long-form in humans and mice
(db/db mice) cause metabolic and reproductive phenotypes
remarkably similar to leptin-deficient subjects [77, 79].
The selective deletion of leptin-induced STAT3 signal-
ing in cells that express LepR (LRbS1138 s/s mice)
recapitulates most of the db/db metabolic phenotype, pro-
ducing hyperphagia, high adiposity and disruption of the
melanocortin circuitry in both males and females [23].
However, these mice show improved glucose homeostasis
and increased body length compared to db/db mice, and
while db/db mice are infertile, a relatively high proportion
(40 %) of LRbS1138 s/s female mice are fertile [23]. All
LRbS1138 s/s females displayed estrous cyclicity, develop-
ment of reproductive organs and ovarian signs of ovulation,
supporting the concept that hypothalamic control of
reproduction by leptin is mediated by a STAT3-indepen-
dent signaling pathway [23]. Subsequent studies have
reported a seemingly contrasting result. Deletion of STAT3
signaling (STAT3N-/-) from the brain (Nestin-Cre mouse
model) resulted in hyperphagic obesity, and high plasma
corticosterone, glucose and insulin levels, similar to ob/ob
and db/db mice [134]. Males and females were infertile
with deficient development of the reproductive organs. In
the attempt to evaluate the contribution of STAT3 signal-
ing pathways to the acute effects of leptin, another group
used stereotaxic injection to deliver a cell-permeable
phosphopeptide inhibitor of STAT3 phosphorylation into
the mediobasal hypothalamus. Females with acute block-
ade of STAT3 in the ventromedial hypothalamus did not
show leptin-induced LH secretion during fasting, indicat-
ing that STAT3 expression in the mediobasal
hypothalamus is required for the acute effects of leptin on
fasting-induced suppression of LH secretion [46]. In this
study, the authors also used genetically modified mouse
models to demonstrate the requirement of STAT3 signaling
for the acute effects of leptin on food intake and glucose
metabolism [46]. Although these mouse studies have gen-
erated some controversies concerning the role of leptin-
induced phosphorylation of STAT3 in reproductive func-
tion, it is important to stress that STAT3 signaling
pathways is not unique to leptin response. STAT3 is a
common transcription factor recruited by several cytokines
including ciliary neurotrophic factor (CNTF) and inter-
leukin 6 (IL6) [38]. Moreover, and of particular relevance
to our topic, estrogen appears to also induce phosphoryla-
tion of STAT3 in mediobasal hypothalamic neurons [133].
Deletion of STAT3 from all cells in the brain or stereotaxic
delivery of STAT3 inhibitor into the mediobasal hypo-
thalamus may block a critical pathway for the control of
reproductive physiology unrelated to leptin signaling.
Endogenous and selective blockade of leptin-induced
STAT3 rendered a mouse model with metabolic features
similar to leptin-signaling deficiency but with improved
fertility, indicating that the full effect of leptin on repro-
duction requires the recruitment of a STAT3-independent
signaling pathway.
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Several studies support the hypothesis that leptin also
engages the phosphoinositide 3-kinase (PI3K) signaling
pathways to exert its effects [243, 250, 352, 363]. For
example, in hypothalamic slices, leptin hyperpolarizes a
subset of arcuate nucleus neurons via activation of an ATP
sensitive potassium channel, resulting in reduced firing
rates [309, 310]. This effect is fully blocked by PI3K
inhibitors [250, 345]. Likewise, the leptin-mediated depo-
larizing effect on proopiomelanocortin (POMC) neurons is
dependent on PI3K signaling and administration of PI3K
inhibitors blunted the ability of ICV leptin to reduce food
intake [156, 250, 363]. In addition, blockade of PI3K sig-
naling precluded the ability of hypothalamic leptin
administration to inhibit white adipose tissue lipogenesis
[45].
The mechanism by which leptin triggers PI3K activity is
thought to be via phosphorylation of insulin receptor sub-
strate-2 (IRS-2) [47, 249]. As the name implies, IRSs are
also implicated in insulin signaling [342], but the extent of
overlap between leptin and insulin cellular responses in
different organs and tissue is still unsettled. IRS-2 is
expressed in hypothalamic sites responsive to leptin and
related to metabolic control, including the arcuate nucleus
and the ventromedial nucleus of the hypothalamus [256].
Global deletion of IRS-2 (IRS-2-/-) in mice cause meta-
bolic dysfunction and female infertility [48]. IRS-2-/-
female mice failed to cycle and ovulate, had decreased
levels of sex hormones and deficient ovarian development.
Interestingly, recent studies have shown that mice with
inactivation of IRS-2 specifically in LepR neurons are
fertile, but whether these mice display regular puberty
onset, cyclicity, sex hormone levels in response to meta-
bolic challenges or advanced or delayed reproductive
senescence has not been reported [279].
Multiple forms of PI3Ks exist. The class 1a enzymes are
heterodimers consisted of one regulatory and one catalytic
subunit. There are typically five regulatory subunits, col-
lectively referred to as p85s, and the catalytic subunits are
comprised of three variants referred to as p110s [58, 331].
Activation occurs when p85 binds to IRS and localizes the
catalytic activity/subunit to the cell membrane, where PI3K
catalyzes the phosphorylation of PIP2 to PIP3 that, in turn,
recruits and activates downstream targets. The PI3K cata-
lytic subunits p110a and p110b are ubiquitously expressed,
and global deletion of either one is embryonically lethal
[29, 30, 69, 159]. However, mice carrying a knock-in
mutation causing a 50 % loss-of-function of p110a activity
are viable, but displayed suppressed IRS-2 signaling and,
thereby, decreased responsiveness to insulin and leptin,
hyperphagia, glucose intolerance and increased adiposity
[125]. Both catalytic subunits are coexpressed in hypo-
thalamic neurons, which express LepR [345]. Selective
deletion of these subunits from LepR-expressing neurons
precludes leptin-induced changes in cellular activity [8,
345]. However, whether the lack of leptin-induced PI3K
signaling results in reproductive deficits has not been
reported.
Another signaling pathway potentially recruited by
leptin is the mammalian target of rapamycin (mTOR) [87].
The mTOR is a highly conserved serine-threonine kinase
downstream of the PI3K–Akt pathway, which is involved
in multiple physiologic regulations. Of importance to this
review is its critical function in the control of growth and
development via the integration of signals from nutrients
and circulating factors [160, 196]. The availability of
nutrients (amino acid L-leucine) and adequate levels of
adenosine-triphosphate (ATP) activate mTOR that, in turn,
induces protein synthesis [147, 160, 287]. Therefore,
mTOR is recognized as a sensor of energy availability in
cellular growth and development. Mutation in the gene
encoding Mtor in mice is embryonically lethal, whereas
increased activity of mTOR induces metabolic dysfunc-
tions including obesity and diabetes [131, 151, 160, 237].
High levels of constitutive mTOR activity down-regulate
insulin and growth factor signaling by decreasing insulin
receptor substrate (IRS1/2) expression and protein stability
[299, 327]. In agreement, the activation of mTOR pathway
is elevated in the liver and in the skeletal muscle of insulin-
resistant obese rats maintained on a high-fat diet, whereas
absence of a downstream mTOR target, the ribosomal S6
kinase (S6K), protects against diet-induced obesity and
enhances insulin sensitivity in mice [183, 328]. Following
this line, leptin administration to rodents induced phos-
phorylation of downstream targets of mTOR (S6K1), and
blockade of mTOR by rapamycin precluded leptin-induced
phosphorylation of S6K1 and the effects of leptin to reduce
food intake [87].
A role for mTOR in the neuroendocrine reproductive
axis of the female rats was reported [273, 274]. Activation
of the mTOR pathway by acute administration of L-leucine
increased LH levels in prepubertal mice, whereas L-leucine
chronic treatment resulted in no changes in puberty onset.
Likewise, L-leucine administration slightly increased LH
levels in caloric restricted prepubertal female rats, but did
not correct the delayed onset of puberty typical of this
experimental model. On the other hand, blockade of mTOR
by central administration of rapamycin delayed puberty
and blunted leptin’s effects in promoting pubertal devel-
opment of food-restricted female rats [273, 274]. It will be
important to define whether this effect is directly associated
with leptin signaling or with a general blockade of a crucial
factor of adequate nutrition and energy availability
required for reproductive function.
Recent studies have also suggested a role for Crtc1
(cAMP-responsive element-binding protein regulated
transcription coactivator-1) linking energy balance and
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reproduction [10]. Crtc1 is a cytoplasmic coactivator
highly expressed in the brain. It translocates to the nucleus
following dephosphorylation induced by cAMP or calcium
activation [35, 295]. Two independent groups have repor-
ted that mice with a loss-of-function mutation in the Crtc1
gene develop obesity [10, 42]. However, infertility was
only observed in one mutant mouse line [10]. Females from
the mutant line generated by Alterejos and colleagues,
displayed low gonadotropin and sex steroids levels, and
lacked development of the reproductive tract. Interestingly,
in this study the authors also demonstrated that leptin
increases the dephosphorylated (nuclear) form of Crtc1,
and thereby regulates the transcription of specific neuro-
peptides involved in the control of the reproductive
physiology (i.e., kisspeptin) [10]. Because of the contrast-
ing findings observed by independent groups using similar
techniques and mouse genetic backgrounds, further studies
will be necessary to evaluate the contribution of Crtc1 to
leptin’s effects on the reproductive neuroendocrine axis.
Brain circuitry engaged in leptin’s action
on reproductive control: redundancies for the benefit
of the species
Leptin receptors are expressed in a wide range of organs
and tissues [361]. However, the literature now converges to
a common view that most of leptin’s actions, including
those in the reproductive neuroendocrine axis, are mediated
by the long-form LepR expressed in the central nervous
system [78, 95]. The initial observations of dense LepR
expression in hypothalamic sites and leptin-induced
increases in LH pulsatility in a variety of species and both
sexes suggested that GnRH neurons are direct targets of
circulating leptin [199, 257, 347, 359]. This concept was
later reinforced by the observation that immortalized
GnRH (GT1) neurons and GnRH-expressing human neu-
roblasts (FNC-B4) express LepR and that leptin may
directly alter GnRH cell activity [217, 236, 313, 361].
However, the expression of the LepR gene in GnRH neu-
rons has been difficult to demonstrate. Recently, with the
use of mouse models expressing reporter genes, it has
become evident that mouse GnRH neurons express virtu-
ally no or very low levels of LepR [100, 208, 269]. The
evaluation of the requirement of LepR expression in GnRH
neurons for sexual maturation and fertility came with the
use of conditional knockout mice. Quennell and colleagues
demonstrated that the deletion of LepR from GnRH neu-
rons produces no identifiable reproductive deficits [269].
Males and females show regular pubertal development, are
fertile and retain normal fecundity. This study determined
that LepR expression in GnRH neurons, if proven, is not
required for leptin’s effects on mouse reproductive
physiology. Therefore, it seems reasonable to assume that
leptin stimulation of GnRH secretion is primarily mediated
by a relay station via interneurons that innervate GnRH
cells. The search for these specific neuronal populations
has become a critical issue to the field.
LepR is highly expressed in numerous brainstem and
hypothalamic sites [59, 113, 121, 231, 232, 242, 294]. In
the brainstem, the nucleus of the solitary tract (NTS) might
possibly mediate leptin’s effects as it functions as a sensory
relay of the internal milieu via vagal afferents or the area
postrema [132, 172, 175]. However, a role for the NTS or
the brainstem in leptin’s action on reproductive control is
unlikely because deletion of LepR selectively from fore-
brain nuclei (CamKIIa-Cre mouse model) produced male
and female mice with reproductive deficits similar to lep-
tin-deficient mice [269]. These findings demonstrate that
leptin action in the brainstem is not required for repro-
ductive function. Rather, LepR-expressing neurons located
in the forebrain are the main players.
Stress-induced disruption of the reproductive function:
the role of the paraventricular nucleus
of the hypothalamus
Food deprivation, severe caloric restriction and negative
energy balance are well-described states of nutritional
stress [74, 93]. In general, stressors of different origins
activate the hypothalamus–pituitary–adrenal (HPA) axis
primarily by inducing the secretion of corticotropin
releasing hormone (CRH) into the hypophyseal portal
system. CRH, in turn, stimulates adrenocorticotropin
(ACTH) release from the anterior pituitary gland and
subsequent corticosterone production from the adrenal
gland [152, 312]. The adenohypophyseal neuroendocrine
CRH neurons are located in the medial parvicellular aspect
of the paraventricular nucleus of the hypothalamus (PVH),
a prominent hypothalamic structure involved in the coor-
dination of a series of neuroendocrine and autonomic
responses [282, 284]. Conditions of nutritional stress (i.e.,
perceived negative energy balance) activate the HPA axis,
concomitant with a decrease in leptin and LH secretion [5,
216, 325]. Exogenous leptin infusion during fasting pre-
vents the activation of the HPA axis and the suppression of
the reproductive axis [5]. In light of these coordinated
responses, several groups have postulated that the negative
energy balance-induced decrease in LH secretion might be
an inhibitory response triggered directly by the high
activity of the HPA axis. The experimental approach
selected to test this model was the use of 2-deoxyglucose
(2DG)-induced blockade of cellular glucose utilization as a
controlled experimental tool that mimics states of starva-
tion. In this paradigm, 2DG increased corticosterone levels,
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and decreased leptin and LH secretion [246, 325, 338].
Pharmacologic inhibition of CRH signaling in 2DG treated
female rats normalized LH levels [325]. However, while
leptin treatment prevented the 2DG-induced increase in
corticosterone, it had no effect on LH secretion [246]. Two
important conclusions can be drawn from these findings:
(a) the restraint of LH pulsatility caused by blockade of
cellular glucose utilization appears to be mediated by CRH
signaling in the brain; and (b) leptin’s induction of LH
secretion during negative energy balance is independent of
the normalization of HPA axis activity and does not
overcome the deleterious effects of lack of glucose
availability.
Leptin-deficient ob/ob mice also exhibit abnormal
stimulation of the HPA axis [106]. Leptin administration to
these mice inhibits the activity of the HPA axis by
decreasing ACTH and corticosterone levels [11, 148].
However, the direct action of leptin on PVH CRH-
expressing neurons is still uncertain and a series of
apparent controversies deserves an attentive look. Early
studies have proposed that leptin’s effect on food intake
may be attained by stimulation—not inhibition—of CRH
neurons. For example, intracerebroventricular administra-
tion of leptin to fasted rats increased CRH mRNA levels in
the PVH [291, 326]. This change was not observed in
LepR-deficient Zucker rats, indicating that it is dependent
on LepR signaling, not secondary to the stress of the
experimental procedure. Leptin also stimulated CRH
secretion from hypothalamic explants of rats and adrenal-
ectomized mice [86, 169]. Because it is reasonable to
expect that stimulation of neuroendocrine CRH neurons
would induce ACTH and corticosterone production, these
findings appear contradictory. However, CRH neurons in
the PVH do not comprise a homogeneous population.
Rather, they consist of neuroendocrine and autonomic
components [281, 284]; therefore, data obtained from
changes in CRH expression in the PVH as a whole may not
be very informative. Moreover, the expression of LepR in
the PVH is very low [59, 100, 113, 294] and the colocal-
ization of LepR in PVH CRH neurons has not been clearly
demonstrated. It is interesting though that leptin induces a
neuronal response (Fos-immunoreactivity) in neurons of
the ventral parvicellular subdivision of the PVH (PVHvp)
in rats [109]. The PVHvp projects to sympathetic and
parasympathetic preganglionic neurons in the brainstem
and spinal cord, and a subset of these neurons coexpress
CRH [281, 283, 316]. However, whether PVHvp CRH
neurons have a critical role in leptin’s physiology is still
unsettled. In any event, leptin’s effect on CRH secretion
and/or neurotransmission appears to be achieved via indi-
rect and/or independent pathways, and the response of
specific neuroendocrine and/or autonomic neuronal popu-
lations may be defined by leptin-responsive neuronal
inputs. One component of this circuitry is the arcuate
nucleus [242, 292], a hypothalamic site, which has been
extensively studied in the context of leptin’s physiology.
Arcuate nucleus: a prime sensor of the internal milieu
The arcuate nucleus (Arc) lies adjacent to the median
eminence, a key circumventricular organ located at the
base of the hypothalamus [43, 132]. The median eminence
contains fenestrated blood vessels that allow diffusion and
interchange of bigger molecules (peptides and hormones)
between the brain parenchyma and the bloodstream. Leptin
can passively penetrate the brain through the circumven-
tricular organs, with the highest levels of labeled-leptin
binding observed in the Arc, surrounding the median
eminence [20]. In the Arc, LepRb is expressed in a subset
of proopiomelanocortin (POMC), neuropeptide Y/agouti
related protein (NPY/AgRP) and Kiss1 neurons [22, 71,
306]. POMC and NPY/AgRP neurons mediate a diverse
range of leptin’s actions in metabolism [82, 114, 235, 290,
344, 348] and several studies have identified these popu-
lations also as key players linking leptin action and
reproduction.
The role of the melanocortin system (POMC and AgRP
neurons) in the control of the HPG axis has been the focus
of contentious debate. This is mainly due to inconsistencies
described by independent laboratories using distinct
approaches and the incomparable phenotypes of different
species, mutant mice and genetically engineered mouse
models. Humans with loss-of-function mutations of mela-
nocortin signaling show no reproductive deficits [117, 190,
355], while in ewes, which are seasonal breeders, studies
indicate that melanocortins relay leptin’s action in the HPG
axis [14, 15]. In rodents, inconsistent findings must be
interpreted based on the experimental design and approach.
Arc POMC neurons project to the preoptic area and make
apparent synaptic contact with GnRH and kisspeptin cells
[89, 201]. One important issue to consider is that POMC, a
complex preprohormone, generates neuroactive peptides
(e.g., b-endorphin/bEnd and a-melanocyte stimulating
hormone/aMSH) with seemingly contradictory effects on
the reproductive axis and metabolism. aMSH reduces food
intake and stimulates lordosis behavior in female rats [6,
82, 141, 349], while bEnd stimulates food consumption
and inhibits GnRH/LH secretion [41, 136, 197]. Moreover,
in rats, aMSH may stimulate or inhibit LH secretion
depending on the internal milieu [66, 293]. Mice with loss-
of-function mutations in Pomc or melanocortin receptors
(Mc3r or Mc4r) genes develop hyperphagic obesity [50, 81,
162] and subfertility later in life. Likewise, mice with a
genetic mutation causing constitutive and ubiquitous
expression of the agouti protein (lethal yellow/Ay)—a
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competitive antagonist of melanocortin receptors—are also
obese and display abnormal estrous cycles and subfertility
at older ages [142]. Whether the reproductive deficits of
these mouse models are secondary to the deleterious effects
of their metabolic dysfunction is currently unknown.
AgRP is expressed in a distinct population of Arc neu-
rons and exhibits an antagonistic effect on melanocortin
receptors [144, 252]. AgRP administration or pharmaco-
logic blockade of MC4R blunted the LH surge in
ovariectomized steroid-primed female rats [286, 336] and
suppressed pulsatile release of LH in ovariectomized rhe-
sus monkey [333]. Notably, in male rats, AgRP increased
GnRH secretion from mediobasal hypothalamic explants
and increased gonadotropins and sex steroids levels when
injected into the cerebral ventricles [311].
These observations, although inconclusive, indicated
that the melanocortin system might also mediate leptin’s
action in the neuroendocrine reproductive axis. Initial
findings demonstrated that in female rats starved for
3 days, leptin administration partially restored the LH
surge but the effect of leptin was blunted in the presence of
MC4R antagonists [336]. However, pharmacological
blockade of MC4R did not prevent the ability of leptin to
activate the HPG axis in ob/ob male mice [157]. Following
the same line, deletion of LepR from POMC neurons,
AgRP neurons, or both POMC and AgRP neurons caused
no reported reproductive deficits in these mice [18, 330]. In
this regard, additional information can be extracted from
leptin-signaling (STAT3)-deficient mice (LRbS1138 s/s). In
these mice, as in db/db and ob/ob mice, the expression of
hypothalamic POMC mRNA was reduced and AgRP
mRNA was increased compared with control mice, dem-
onstrating that STAT3 is required for the regulation of both
mRNAs [23]; but while db/db and ob/ob mice were
infertile, s/s mice showed improved fertility indicating that
normalization of melanocortin levels in the brain is not
required for improvement of the reproductive function. It is
interesting that deletion of LepR and insulin receptor
selectively from POMC cells generated a mouse model
with insulin resistance, hyperandrogenism, ovarian abnor-
malities and late onset of subfertility [154]. However, as
noted before, it is not yet clear if the reproductive deficits
observed also in this mouse model are caused by disruption
of a direct melanocortin action on GnRH secretion or are
secondary to their impaired metabolic function. Collec-
tively, these findings indicate that, despite the initial
evidence in female rats, leptin action in melanocortin
neurons is not required for the development and maturation
of the reproductive system in mice.
Studies from two independent laboratories have dem-
onstrated that ablation of AgRP neurons or knockout of one
allele of Mc4r gene corrected the infertility phenotype of
leptin-signaling-deficient mice [167, 351]. These
publications clearly demonstrate that, although leptin
action in melanocortin neurons is not required for repro-
ductive function, blockade of a likely inhibitory action of
AgRP on GnRH secretion is sufficient to improve fertility
in leptin-signaling-deficient mouse models.
AgRP neurons coexpress the inhibitory neurotransmitter
GABA, and NPY, a potent orexigenic peptide highly
implicated in leptin’s physiology [76, 82, 114, 144, 178,
290, 348, 350]. The actions of NPY in reproductive control
are highly dependent on several factors including steroid
milieu, stage of development and expression of sex steroids
receptors [155, 346]. Administration of NPY to ovariec-
tomized steroid-primed rats increases LH secretion [168,
179, 278, 329]. In contrast, in the absence of gonadal ste-
roids or in intact rats, NPY inhibits reproductive function
as seen by decreased circulating levels of gonadotropins
and sex steroids, decreased weight of the reproductive
organs and decreased copulatory behavior in both sexes
[76, 230, 260, 270, 353]. Intracerebroventricular adminis-
tration of NPY antisera or blockade of NPY gene
expression by antisense oligonucleotides diminished pul-
satile GnRH secretion [176, 353], whereas NPY stimulated
the release of GnRH from mediobasal hypothalamic
explants and potentiated GnRH-stimulated gonadotropin
release from the anterior pituitary gland [90, 177]. These
findings may appear contradictory, but it is important to
stress that NPY is expressed in several other brain sites
outside the Arc, making some of the reports difficult to
interpret or reconcile.
Conditions of negative energy balance such as food
restriction, excess exercise and lactation, have been asso-
ciated with elevated levels of hypothalamic NPY
expression, and leptin-signaling-deficient obese mice
exhibit high levels of Arc NPY [6, 267, 290, 307, 348].
Thus, it is reasonable to believe that high NPY expression
in the Arc contributes to the decreased fertility observed in
these conditions [13]. To test this hypothesis, a series of
mouse models were generated. NPY knockout mice and
mice with selective deletion of LepR from NPY/AgRP
neurons display normal reproductive function [115, 330],
but deletion of Npy gene expression in leptin-deficient
ob/ob mice improve their fertility [115]. One-third of
double mutant NPY-/-ob/ob male and 20 % of female
mice were fertile. Because previous studies have shown
that food restriction ameliorates the reproductive capacity
of ob/ob male mice [194], it will be important to define
whether the improved fertility of the NPY-/-ob/ob mice is
secondary to an improvement of their metabolic profile
(e.g., decreased hyperglycemia and reduced adiposity).
The Arc houses one of the most potent regulators of the
reproductive physiology, the kisspeptins (products of the
KISS1/Kiss1 gene). A series of excellent reviews focused
on the kisspeptin role in reproductive biology have been
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published in the last few years and may be consulted for
further details [80, 251, 263, 320]. Loss-of-function
mutations in KISS1/Kiss1 or the kisspeptin receptor
(GPR54/Gpr54) genes causes infertility due to lack of
pubertal development and hypogonadotropic hypogonad-
ism in humans and mice [92, 96, 195, 297, 323]. A steady
increase in hypothalamic Kiss1 and Gpr54 gene expression
is observed across pubertal development and administra-
tion of kisspeptin to juvenile rodents induces vaginal
opening, increases LH secretion and induces ovulation
[247, 300, 319]. Notably, a subset of Kiss1 neurons in the
Arc coexpress LepR but, in this regard, some inconsis-
tencies are apparent. Using dual-labeled in situ
hybridization in castrated male mice, Smith and colleagues
reported 40 % Kiss1/LepR colocalization [306]. In ovari-
ectomized guinea pig, Qiu and collaborators reported 80 %
of Kiss1/LepR colocalization using electrophysiologic
recordings and single cell PCR of Arc neurons [265]. In
contrast, minimal colocalization has been reported using
different lines of female Kiss1 reporter mice and female
rats [89, 208, 324]. In female mice engineered to express
green fluorescence protein (GFP) in Kiss1 neurons (or
Tachykinin 2-expressing neurons), less than 10 % Kiss1/
LepR coexpression was reported in intact mice and 15 %
colocalization was found in ovariectomized mice [89, 208].
In female rats, no colocalization has been observed [324].
Different techniques or approaches (e.g., dual in situ
hybridization, dual immunohistochemistry, single cell
PCR, reporter mice), species differences (i.e., mouse, rat
and guinea pig) or the existence of an unreported sexual
dimorphism in the response of Kiss1 neurons to leptin may
account for these discrepancies. However, the percentage
of colocalization is not always a good indicative of phys-
iological relevance. For example, only around 30 % of
POMC neurons coexpress LepR, but their role in leptin’s
physiology is unequivocal [110, 290, 343, 344]. Following
this concept, the requirement of leptin action in Kiss1
neurons was assessed with the use of conditional knockout
mice (Cre–loxP system) in which LepR was selectively
deleted from Kiss1 neurons [101]. Male and female Kiss1-
Cre/LepR-floxed mice showed normal pubertal develop-
ment, sexual maturation and fertility, indicating that direct
leptin action in Kiss1 neurons is not required for normal
puberty onset and reproduction, in mice. Notably, a recent
report demonstrated that female mice with ablation of
kisspeptin neurons early in development exhibited no
deficits in pubertal development and fertility [226]. While
intriguing, this finding suggests that developmental adap-
tations may be triggered to allow reproduction and species
survival. Therefore, it is also possible that systems redun-
dancy and/or developmental adaptations may occur in mice
with lack of leptin signaling in kisspeptin neurons. Addi-
tional studies will be necessary to test this hypothesis.
Several groups have reported a decrease in Kiss1 mRNA
expression and kisspeptin production in conditions of low
leptin levels (e.g., ob/ob mice or wild-types in negative
energy balance) [63, 174, 212, 268, 306]. Moreover,
streptozotocin-injected diabetic male rats displayed
decreased levels of hypothalamic Kiss1 mRNA concomi-
tant with low circulating levels of leptin, insulin, LH and
androgens [64]. Administration of leptin, but not insulin,
increased hypothalamic Kiss1 gene expression, and levels
of LH and androgens. Collectively, these studies indicate
that leptin administration may restore (or increase) Kiss1
mRNA expression in rodents in negative energy balance.
Whether this effect is achieved via direct leptin action in
Kiss1 neurons or by the stimulation of leptin-responsive
neurons that project to kisspeptin, still needs to be
determined.
The existence of a complex interplay among Kiss1,
POMC and NPY/AgRP neurons in the Arc has been
reported [15, 16, 128]. For example, the melanocortin
system may influence the reproductive physiology of ewes
via actions in kisspeptin-expressing cells [15]. In mice,
subpopulations of kisspeptin neurons in the preoptic area
and Arc coexpress MC4R and, therefore, are also apt to
respond to the melanocortin system [89]. As an alternative
pathway, leptin may influence Kiss1 expression via pro-
jections from the ventral premammillary nucleus, a brain
site recently shown to play a fundamental role in leptin’s
action on reproductive control [98, 101, 203, 208].
Ventral premammillary nucleus: the emergence
of a forgotten pathway
Initial evidence for a role of ventral premammillary
nucleus (PMV) neurons in reproductive control came from
studies in rats focused on the contribution of sex odorants
to the activation of the HPG axis. In response to opposite
sex odors, males and females from different species exhibit
increased circulating levels of gonadotropins and sex ste-
roids [26, 85, 180, 214, 223, 264]. Odors are relayed by the
main and accessory olfactory pathways and converge in the
medial nucleus of the amygdala which in turn innervates
several hypothalamic nuclei related to behavioral adjust-
ments and hormonal secretion, including the PMV [57,
145, 285, 357]. In female rats on proestrus, electrical
stimulation of the medial nucleus of the amygdala pre-
cipitated LH secretion [25], a response that is blocked in
rats with electrolytic lesions of the PMV [27]. Following
copulation, PMV neurons appear activated (Fos immuno-
reactivity), a response that was later shown to be related to
odor stimulation [65, 99, 188, 203, 356]. Projections from
the PMV are particularly dense in forebrain sites related to
the control of the HPG axis, in sexually dimorphic nuclei
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and in those components of vomeronasal circuitry [55,
275]. In particular, the PMV innervates kisspeptin neurons
and GnRH cells in the preoptic area as well as GnRH
terminals in the mediobasal hypothalamus/median emi-
nence [37, 101, 203, 208, 275]. In addition, a high-to-
moderate density of sex steroids-responsive neurons
(estrogen receptors and androgen receptor) is also found in
the PMV of rodents [233, 304]. Thus, PMV neurons are
likely to integrate and convey sexually relevant signals
from external and internal environments to relevant
reproductive control sites in the brain.
The PMV houses a high density of neurons expressing
LepR. Of these, a high proportion is depolarized (and most
likely activated) by leptin [109, 113, 203, 208, 345]. These
neurons coexpress the neurotransmitters glutamate and
nitric oxide, and directly innervate GnRH cells [101, 102,
203, 208]. Together, these findings indicate that PMV
neurons are potentially stimulated by leptin and may
directly activate their terminal targets (e.g., kisspeptin and
GnRH neurons) via the release of glutamate, a classical
excitatory amino acid [39, 219].
The role of PMV neurons as a key site of leptin action in
reproductive control has only recently been demonstrated
in a series of experiments using conditional knockouts and
excitotoxic lesions in rats and mice. Female rats with
bilateral lesions of PMV neurons became anestrus during a
transient period of 2–3 weeks [98]. After this time, their
cyclicity was apparently normalized but, during proestrus,
PMV-lesioned rats showed reduced estradiol and LH lev-
els, GnRH mRNA expression and decreased activation of
GnRH and AVPV neurons. Leptin administration to fasted
PMV-lesioned rats failed to increase LH secretion, indi-
cating that the PMV is a critical site for the stimulatory
effects of leptin on fasting-induced suppression of the HPG
axis. However, it is important to emphasize that only a
subset of PMV neurons coexpress LepR [203] and, there-
fore, the effects of the excitotoxic lesions might result from
disruption of pathways unrelated to leptin’s physiology, but
involved in the control of female neuroendocrine repro-
ductive axis. Thus, to assess the role of PMV in leptin’s
physiology, a more selective approach was performed
using the conditional knockout technique, in which LepR
was endogenously re-expressed in PMV neurons of a LepR
null reactivable mouse model [84, 101]. Re-expression of
LepR selectively in PMV neurons of LepR null female
mice induced pubertal development and improved fertility;
but, intriguingly, no amelioration of male infertility was
observed [101]. These findings demonstrated that leptin
action in PMV neurons of female mice is sufficient to
induce puberty and improve fertility in the otherwise
infertile LepR null mice. They also indicate that leptin’s
action in the reproductive function is sexually dimorphic
and that alternative brain sites relay leptin’s effects in
male’s reproduction. As discussed in previous sections,
neurons in the Arc may convey signals from leptin levels to
the male reproductive system. The role of LepR in the male
PMV neurons still needs to be unraveled.
Due to the expected redundancy of the system, leptin
action in PMV neurons may be sufficient but not required
for reproduction in female mice. To test this, a more pre-
cise approach would be the selective deletion of LepR from
PMV neurons using the Cre–loxP system. However, due to
the lack of a mouse model in which Cre recombinase is
driven by a gene expressed exclusively in PMV neurons,
another strategy was used. PMV neurons of ob/ob female
mice were ablated by the bilateral administration of an
excitotoxic agent (NMDA) and leptin was replaced in these
mice. In PMV-lesioned ob/ob mice, a significant delay in
pubertal development was observed indicating that leptin
action in the female PMV is required for an adequate
maturation of the reproductive system [101]. However,
after 35–40 days in the presence of a sexually experienced
male, 80 % of the PMV-lesioned mice showed sexual
maturation as indicated by the presence of copulatory
plugs, suggesting that alternative/redundant pathways (e.g.,
melanocortin system) were recruited to allow reproductive
success. In agreement, deletion of LepR selectively from
neurons expressing neuronal nitric oxide synthase (nNOS)
delayed pubertal maturation in female mice [202]. LepR
and nNOS are colocalized in neurons of several nuclei,
including the PMV where colocalization rate is very high
[102, 202, 203] reinforcing the relevance of PMV neurons
as key site of leptin action in pubertal initiation.
Of note, several studies have suggested that leptin
facilitates sexual behavior in female hamsters and rats
[135, 334]. The brain pathways involved in this effect by
leptin are not known and the involvement of PMV neurons
in the control/modulation of sexual behavior in males or
females has not been demonstrated. However, it is inter-
esting that a strong interconnection between the PMV and
the ventrolateral subdivision of the ventromedial nucleus of
the hypothalamus, a key site in female sexual behavior, has
been reported [55, 56, 275]. The physiologic relevance of
these reciprocal connections awaits further investigation.
From satiety center to behavioral gate: the many faces
of the ventromedial nucleus of the hypothalamus
The ventromedial nucleus of the hypothalamus (VMH) has
been the focus of the attention of many laboratories inter-
ested in the complex regulation of energy homeostasis since
the seminal report by Hetherington and Ranson [153]. This
study showed that bilateral electrolytic lesions centered in
the VMH induce hyperphagic obesity, characterized by a
remarkable increase in the adipose tissue mass.
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Subsequently, it was suggested that the lesions may have
disrupted the internal connectivity of the medial hypotha-
lamic nuclei and that other hypothalamic sites, including the
PVH, may have played a major role in this phenotype [114,
139]. The relevance of the VMH in metabolic regulation was
reinstated with the demonstration of dense expression of
receptors for metabolic cues (e.g., leptin and ghrelin) and the
presence of glucosensing neurons [112, 113, 181, 277, 294,
308, 364]. However, the VMH, like most of the hypotha-
lamic nuclei, is not a homogeneous structure. Rather, it is
composed of distinct subdivisions with characteristic pro-
jection patterns [56]. The ventrolateral subdivision of the
VMH (VMHvl) expresses sex steroids receptors, projects to
reproductive control sites and plays a well-defined role in the
female sexual behavior [56, 94, 233, 305]. On the other hand,
neurons in the dorsomedial subdivision of the VMH
(VMHdm) are responsive to metabolic cues (e.g., leptin and
insulin) and project to sites related to autonomic and circa-
dian regulation [111, 185, 187]. Therefore, neurons in the
VMHdm may influence energy balance by modulating
autonomic responses, which include thermogenesis, hepatic
glucose production, glucose utilization and secretion of
insulin and glucagon [28, 88, 186, 210, 248].
The VMH is virtually the only site in the brain where the
steroidogenic factor-1 (SF1) is expressed [163, 296]. SF1 is
also found in gonads, adrenal and pituitary gland and, as
the name implies, it is a key component of the steroido-
genic cascade. Mice with deletion of SF1 gene (Nr5a1)
show adrenal and gonadal agenesis, disrupted VMH for-
mation and infertility [164, 211, 280, 302]. Notably,
deletion of SF1 selectively from the central nervous system
(i.e., from the VMH) disrupted VMH neuronal connectivity
and impaired female reproductive function [184]. These
findings make the VMH a potential candidate to mediate
the effects of leptin in reproductive control. Using the SF1-
Cre mouse model, two independent groups demonstrated
that leptin signaling in VMH neurons is required for body
weight homeostasis and adequate control of glycemia and
thermogenesis [32, 97], but these mice (both male and
female) are fertile. Thus, it was concluded that leptin sig-
naling in the VMH is not required for leptin’s effect in
reproductive control. But as noted before, developmental
adaptations and the redundancy of the reproductive cir-
cuitry should be taken into account. Further studies will be
necessary to assess whether mice with leptin signaling only
in VMH neurons show improvements in any aspect of their
reproductive physiology.
Relevance for reproductive human health
Our understanding of leptin’s biology has largely grown
from experiments in rodents, but a series of studies has also
been conducted in humans, demonstrating the unequivocal
relevance of leptin for human’s reproductive health.
Women have higher leptin levels compared to men [229].
This difference is already apparent at birth; leptin is higher
in cord blood of female infants [170, 225, 289]. In girls, a
direct relationship between the increase in leptin and
gonadal steroid levels has been observed during pubertal
development, likely consequent to the increase in body fat.
In late puberty, leptin levels are also higher in females
[158]. Due to its strong positive correlation with BMI,
higher leptin in women has been attributed to a higher
adiposity [229]. However, in a cross sectional study of 204
subjects, gender differences in leptin levels persisted even
when adjusted for body fat [149, 253]. Moreover, studies
demonstrated that women also have higher leptin pulsatil-
ity over a 24-h period [204, 229, 289]. Although still
undefined, a plausible explanation for the gender difference
could be the effects of testosterone to likely decrease leptin
levels in men [213].
As discussed previously, leptin levels fall in states of
acute energy deprivation, and this physiologic response is
seen as an adaptive strategy of diverting energy resources
away from processes that are not essential for immediate
survival. Extreme exercise (e.g., ballet dancers and gym-
nasts) and anorexia nervosa are associated with low
gonadotropin and leptin levels [105, 224, 340]. Nutritional
support to patients with anorexia nervosa improved percent
body fat, BMI, leptin and gonadotropin secretion [17].
Likewise, secondary amenorrhea has been associated with
decreased leptin levels (\2 mcg/l) [189]. Leptin treatment
in women with functional hypothalamic amenorrhea
caused by increased exercise and decreased body weight
improved gonadotropin pulsatility, endometrial thickness,
ovarian volume and ovulation [341]. In addition, leptin
treatment in 72-h fasted healthy men prevented the dis-
ruption of gonadotropin secretion [67].
Obese individuals are usually in a state of hyperleptin-
emia and leptin resistance [229, 301]. However, the direct
adverse effects of high leptin levels on reproduction in
obesity are not well defined. Hyperleptinemia has been
shown to interfere with ovulation and inhibit follicular
growth in mice ovaries [315]. In humans, studies in vitro
showed that higher doses of leptin can interfere with the
ability of the dominant follicle to produce estradiol by
inhibiting the production of androgen substrate and
decreasing the aromatization capacity of granulosa cells [1].
In obese men, fat mass and leptin are inversely correlated
with circulating levels of testosterone. Moreover, following
human chorionic gonadotropin (hCG) stimulation, obese
individuals exhibited higher 17-hydroxyprogesterone
(17-OHP)/testosterone ratio compared to control lean sub-
jects. These findings suggest the existence of an enzymatic
dysfunction in the conversion of 17-OHP to testosterone in
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the Leydig cells [166]. Whether this effect is caused by
excess leptin needs further investigation.
Controversies regarding the association of leptin with
polycystic ovarian syndrome (PCOS) exist. One study
found that leptin levels are elevated in women with PCOS
[44]. However, the investigators did not adjust their data
for BMI or fat mass and therefore the relevance of their
findings has been debated. Moreover, subsequent studies
were not able to reproduce this initial data, refuting the
concept that changes in leptin levels might play a role in
the etiology of PCOS [138, 222, 261, 276, 298].
Lipodystrophy is associated with low leptin levels. In
particular, leptin is marked reduced in individuals with
congenital generalized lipodystrophy (CGL) and acquired
generalized lipodystrophy (AGL), compared to familial
partial lipodystrophy (FPL) and acquired partial lipodys-
trophy (APL) [146]. The prevalence of infertility and
PCOS is higher in patients with lipodystrophy compared to
the general population [173, 332]. Leptin therapy improved
insulin sensitivity, decreased testosterone levels, increased
sex hormone binding globulin (SHBG) and reversed the
features of PCOS [209]. Recently, an interesting case has
been reported of a young woman with CGL, undetectable
leptin levels and primary amenorrhea who after treatment
with leptin underwent menarche and adequate sexual
maturation. Leptin therapy improved her metabolic com-
plications and reproductive dysfunctions. The patient
eventually became pregnant and was able to delivery at
37 weeks of gestation with minimal complications [218].
Conclusion
In recent years, the use of genetic modified mouse models
and the advance of molecular mapping of brain circuitry
have generated a considerable amount of information
regarding leptin’s action in the reproductive neuroendo-
crine axis. Using these techniques we have learned that
leptin activates glutamatergic PMV neurons and inhibits
GABAergic AgRP Arc neurons. Both populations, in turn,
impinge on GnRH and/or kisspeptin neurons, potentially
modulating the reproductive neuroendocrine axis. The
integration of these opposite signals is crucial to the control
of timely secretion of GnRH during pubertal maturation
and in states of energetic challenges. Importantly, lack of
leptin action in one of these neuronal groups does not
preclude sexual maturation, indicating that one neuronal
population can compensate the effects of the other. These
redundancies and systems plasticity are fundamental fea-
tures in reproductive biology, allowing procreation and
species survival. In addition, the identification of alterna-
tive signaling pathways recruited by leptin will allow a
better understanding of the mechanisms by which leptin
acts as a permissive factor in pubertal maturation and
reproduction.
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